Ocugen Inc. Announces John Paul Gabriel as Senior Vice President, Manufacturing and Supply Chain
John Paul (J.P.) Gabriel John Paul (J.P.) Gabriel MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN),...
News
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
SAN DIEGO, April 14, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery...
Odyssey Group International Announces Formation of Scientific Advisory Board
Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and...
Lowell Farms and Ascend Wellness Holdings Announce Strategic Licensing Agreement, Bringing Award-Winning Lowell Smokes to Illinois and Massachusetts
Lowell Smokes award-winning pre-rolls available this summer in two of the top four largest cannabis markets outside of the West...
Inovalon Announces First Quarter 2021 Earnings Conference Call
BOWIE, Md., April 14, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare,...
Inozyme Pharma Presents Data from Burden of Illness Study in Patients with ENPP1 Deficiency and ABCC6 Deficiency at the 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics
- Study results underscore high and shifting disease impacts across age groups, reflecting evolution of disease symptomology -BOSTON, April 14,...
Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank
DURHAM, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human...
Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
MONTREAL, April 14, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused...
Amedisys to Acquire Randolph County Home Health Regulatory Asset
BATON ROUGE, La., April 14, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice...
Axogen, Inc. to Report First Quarter Financial Results and Host Conference Call on May 5, 2021
ALACHUA Fla. and TAMPA, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing...
Teladoc Health to Announce First-Quarter Financial Results
PURCHASE, NY, April 14, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,...
RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform
Agreement provides RenalytixAI with exclusive option to access intellectual property surrounding a comprehensive panel of novel biomarkers in kidney diseaseNEW...
Skylight Health to Present at Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a...
Coya Therapeutics™ Announces the Appointment of Hideki Garren, M.D., Ph.D., and Dov Goldstein, M.D., to Its Board of Directors
HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous...
Zymergen Announces Launch of Initial Public Offering
EMERYVILLE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced...
CENTOGENE Extends Partnership With Takeda
CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused...
Tauriga Sciences Inc. Confirms Substantial Pre-Orders for its 25mg CBD & CBG Infused Tauri-Gum
Tauriga 04-14-2021 Pomegranate Blister Pack Design: 25mg CBD Tauri-Gum™ NEW YORK, NY, April 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...
Vascular Biogenics Ltd. Closes Public Offering of Ordinary Shares and Pre-Funded Warrants
TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today...
Highlight to present Phase 2 data at AACR
Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual...
GN Store Nord upgrades financial guidance for 2021
GN Audio upgrades 2021 financial guidance following an extraordinarily strong start to 2021GN Hearing confirms 2021 financial guidanceGN Store Nord...